Australia markets close in 11 minutes

Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
20.23-1.29 (-5.99%)
At close: 03:29PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 12.64B
Enterprise value 12.52B
Trailing P/E 34.71
Forward P/E 51.02
PEG ratio (5-yr expected) 43.66
Price/sales (ttm)9.42
Price/book (mrq)11.31
Enterprise value/revenue 6.53
Enterprise value/EBITDA 15.55

Trading information

Stock price history

Beta (5Y monthly) -0.29
52-week change 3-11.44%
S&P500 52-week change 318.79%
52-week high 326.46
52-week low 319.61
50-day moving average 322.09
200-day moving average 322.50

Share statistics

Avg vol (3-month) 31.13k
Avg vol (10-day) 31.98k
Shares outstanding 5577.05M
Implied shares outstanding 6N/A
Float 8574.57M
% held by insiders 16.46%
% held by institutions 129.64%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.23
Forward annual dividend yield 41.06%
Trailing annual dividend rate 30.39
Trailing annual dividend yield 31.81%
5-year average dividend yield 41.52
Payout ratio 442.32%
Dividend date 3N/A
Ex-dividend date 401 Dec 2021
Last split factor 25:1
Last split date 303 Oct 2004

Financial highlights

Currency in NZD.

Fiscal year

Fiscal year ends 30 Mar 2021
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 26.54%
Operating margin (ttm)35.98%

Management effectiveness

Return on assets (ttm)23.98%
Return on equity (ttm)36.99%

Income statement

Revenue (ttm)1.96B
Revenue per share (ttm)3.40
Quarterly revenue growth (yoy)-1.10%
Gross profit (ttm)1.25B
EBITDA 781.8M
Net income avi to common (ttm)520.5M
Diluted EPS (ttm)0.61
Quarterly earnings growth (yoy)-1.60%

Balance sheet

Total cash (mrq)288.4M
Total cash per share (mrq)0.5
Total debt (mrq)114.5M
Total debt/equity (mrq)7.20
Current ratio (mrq)2.76
Book value per share (mrq)2.76

Cash flow statement

Operating cash flow (ttm)534.7M
Levered free cash flow (ttm)298.01M